Trial intelligence / Profile preview

Tafoxiparin for Prevention of Prolonged Labor

NCT00710242Phase 2Completed

Sponsor
Dilafor AB
Start
Apr 2007
Primary completion
Mar 2009
Modality
Bivalent/Multivalent Binders
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in prolonged labor comparing Tafoxiparin with Placebo (2 arms). Primary endpoint: Time from the time of at least 3 cm cervix dilatation and 3 contractions of minimum one minute's duration/10 minutes until partus. Started Apr 2007; status: completed.

02

Drugs

tafoxiparin
03

Conditions

prolonged labor

Beyond the preview

Go deeper on NCT00710242.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00710242.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call